Eric I Richman's Net Worth
Eric I Richman's net worth is estimated to be at least $233,868.35 as of 12/27/2024. CoreStreet's estimation of Eric I Richman's net worth is based on their sale of stock and current holding of stock.
Eric I Richman is Director at Gain Therapeutics Inc. They have executed at least 9 trades of stock as per SEC Form 4 filings. Their most recent trade was for 17,000 units of GANX stock on 07/01/2024. Their biggest sale was on when they sold units of stock for $. They typically trade 1 times per year.
Total value of insider buys:
- $233,868.35
Total value of insider sells:
- $0.00
Most recent insider trade:
- July 1, 2024
Eric I Richman's Insider Trading History
| Gain Therapeutics Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
July 1, 2024 | Director | 17,000 | $1.22 | Buy | $20,740.00 |
May 25, 2022 | CEO | 2,482 | $2.58 | Buy | $6,403.56 |
May 19, 2022 | CEO | 4,000 | $2.71 | Buy | $10,840.00 |
| NeuBase Therapeutics Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
March 3, 2022 | Director | 1,300 | $1.72 | Buy | $2,236.00 |
March 1, 2022 | Director | 1,580 | $1.58 | Buy | $2,496.40 |
April 26, 2021 | Director | 5,000 | $5.00 | Buy | $25,000.00 |
April 30, 2020 | Director | 10,833 | $7.83 | Buy | $84,822.39 |
| ADMA Biologics Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Nov. 9, 2017 | Director | 25,000 | $2.15 | Buy | $53,750.00 |
March 13, 2015 | Director | 3,500 | $7.88 | Buy | $27,580.00 |